Therefore, blocking the CSF1/CSF1R pathway could effectively prevent macrophage recruitment and M2 phenotype polarization, activate CD8+ T cells, and sensitize HCC to anti-PD-L1 immune checkpoint blockade (Figure 2) [157]. Here, CD8A is linked to hepatocellular carcinoma.